FierceBiotech
  • FierceBiotech
  • FierceBiotechIT
  • FierceBiotechResearch
  • FierceBiomarkers
  • FierceDrugDelivery
  • FierceMedicalDevices
  • FierceVaccines
  • FiercePharma
  • FiercePharmaManufacturing
  • FierceCRO
  • More Fierce Network sites
  • Select another site
  • Advertise
  • Contact

Free Daily Biotech Industry Newsletter Get the latest on Biotech & Pharma Deals, Clinical Trials, FDA Decisions, and Key Regulatory Issues sent straight to your Inbox. Join over 100,000 biotech professionals who subscribe to FierceBiotech for FREE! Click here to see a sample.

FierceBiotech

  • News
  • TOPICS
    • Biosimilars
    • Chutes and Ladders
    • Clinical Trials
    • Drug Safety
    • Emerging Markets
    • Europe
    • M&A
    • Outsourcing
    • Partnering
    • Personalized Medicine
    • Pipeline
    • R&D
    • Regulatory
  • ANALYSIS
    • Third Rock's Levin calls for teamwork in personalized medicine
      by Damian Garde
    • Readers' picks, responses to Fierce's 'Top 10' cancer drugs report
      by Ryan McBride
    • More commentary
  • FEATURES
    • The Biggest R&D Spenders in Biotech
    • The Biggest R&D Spenders In Biopharma
    • Top 10 Late-Stage Cancer Drugs – 2012
  • LIBRARY
    • Webinars
    • View All
  • EVENTS
  • JOBS
    • Browse Jobs
    • Post a Job
  • Marketplace
  • Susbscribe
  • Twitter
  • Mobile
Follow US
Tag:

FibroGen

Latest Headlines

Latest Headlines

Related Tags

  • Eli Lilly
  • Amgen
  • Arena Pharmaceuticals
  • Sensipar

FibroGen Press Releases

  • FibroGen Appoints Michael Martinelli, Ph.D., Vice President of Technical Development
  • FibroGen Announces Initiation of Phase 2b Studies of FG-4592, an Oral HIF Prolyl Hydroxylase Inhibitor, for Treatment of Anemia

Join 100,000+ Insiders SIGN UP FOR OUR NEWSLETTER

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

  • MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
  • Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
  • What's your BIO?June 18-21, 2012 — Boston, MA
MORE EVENTS

Press Releases

  • Chronic Pain Is Relieved by Cell Transplantation in Lab Study
  • Drug-vaccine combo better for breast cancer
  • Marked for destruction: Newly developed compound triggers cancer cell death
  • Orthofix International Completes Divestiture of Sports Medicine Business Unit
  • ConforMIS iTotal CR Knee Replacement System Wins Silver in 2012 Medical Design Excellence Awards
  • More Press Releases

Featured Jobs

  • Entry Level Process Engineer and Lead Process Engineer
    Foster Wheeler Biokinetics - San Francisco, CA
  • Sr. Director/Executive Director of Operations, Inflammation and Immunology CRD Job
    Celgene Corporation - Tokyo, Ja, US
  • Food Development Scientist Job
    Yoh - Park Ridge, NJ, USA
  • Aseptic Operations Manager
    DPT Labs - Lakewood, NJ
  • Regulatory Scientist Assistant III (Senior) Job
    Yoh - Kenilworth, NJ, USA

A publication of FierceMarkets

FierceBiotech monitors biotech & pharma deals, FDA decisions, clinical trials, and more. Join more than 100,000 biotech industry leaders who subscribe to our free daily email. Click here to get your free weekly email briefing today!

The FierceMarkets Network:

Telecom
  • FierceWireless
  • FierceBroadbandWireless
  • FierceMobileContent
  • FierceDeveloper
  • FierceWireless:Europe
  • FierceTelecom
  • FierceEnterpriseCommunications
  • FierceIPTV
  • FierceOnlineVideo
  • FierceCable
Healthcare
  • FierceHealthcare
  • FiercePracticeManagement
  • FierceHealthIT
  • FierceHealthFinance
  • Hospital Impact
  • FierceEMR
  • FierceMobileHealthcare
  • FierceHealthPayer
Government
  • FierceGovernment
  • FierceGovernmentIT
  • FierceHomelandSecurity
Energy
  • FierceEnergy
  • FierceSmartGrid
Life Sciences
  • FierceBiotech
  • FierceBiotechResearch
  • FiercePharma
  • FierceVaccines
  • FierceBiotechIT
  • FiercePharmaManufacturing
  • FierceMedicalDevices
  • FierceDrugDelivery
  • FierceBiomarkers
  • FierceCRO
Enterprise IT
  • FierceCIO
  • FierceCIO:TechWatch
  • FierceMobileIT
  • FierceContentManagement
Finance
  • FierceFinance
  • FierceComplianceIT
  • FierceFinanceIT
  • Home
  • Subscribe
  • Advertise
  • Mobile Edition
  • RSS
  • Privacy
  • Editors
© 2012 FierceMarkets. All rights reserved.